| |
XB130 expression |
|
| Clinicopathological features |
No. of cases |
Positive(+) |
Negative(-) |
p-value |
| Tissue |
|
|
|
0.0001 |
| Normal tissue |
60 |
0(100%) |
60(100%) |
|
| Osteosarcoma tissue |
60 |
24(40%) |
36(60%) |
|
| Age(year) |
|
|
|
0.327 |
| >20 |
19 |
7(36.8%) |
12(63.2%) |
|
| ≤20 |
41 |
17(41.4%) |
24(58.6%) |
|
| Gender |
|
|
|
0.486 |
| Female |
22 |
8(36.4%) |
14(63.6%) |
|
| Male |
38 |
16(42.1%) |
22(57.9%) |
|
| Tumor metastasis |
|
|
|
0.001 |
| Yes |
19 |
16(84.2%) |
3(15.8%) |
|
| No |
41 |
8(19.5%) |
33(80.5%) |
|
| Size of primary OS(cm) |
|
|
|
0.187 |
| <8 |
28 |
9(32.1%) |
19(67.9%) |
|
| ≥8 |
32 |
15(46.9%) |
17(53.1%) |
|
| Clinical stage |
|
|
|
0.002 |
| Ⅰ/ⅡA |
23 |
4(17.4%) |
19(82.6%) |
|
| ⅡB/Ⅲ |
37 |
20(54%) |
17(46%) |
|
| Histologic type |
|
|
|
0.632 |
| Osteoblastic |
30 |
12(40%) |
18(60%) |
|
| Chondroblastic |
11 |
5(45.4%) |
6(54.6%) |
|
| Fibroblastic |
12 |
5(41.7%) |
7(58.3%) |
|
| Mixed |
6 |
2(33.3%) |
4(66.7%) |
|
| Location |
|
|
|
0.894 |
| Femur |
25 |
11(44%) |
14(56%) |
|
| Tibia |
18 |
6(33.3%) |
12(66.7%) |
|
| Humurs |
9 |
4(44.4%) |
5(55.6%) |
|
| Others |
8 |
3(37.5%) |
5(62.5%) |
|
| Response to chemotherapy |
|
|
|
0.086 |
| Good |
21 |
7(33.3%) |
14(66.7%) |
|
| Poor |
39 |
17(43.6%) |
22(56.4%) |
|
|
